From the ∗Rheumatology Department, Carlos G. Durand Hospital, Buenos Aires, Argentina

†Internal Medicine Department, Centre Hospitalier Universitaire de Nantes, Nantes, France

‡Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain

§Rheumatology Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium

∥Rheumatology Department, Hospital Interzonal General de Agudos San Martin de La Plata, La Plata, Argentina

¶Division of Rheumatology, Northwell Health, Great Neck, NY

#Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, OH

∗∗Division of Rheumatology and Clinical Immunology, The University of Alabama at Birmingham, Birmingham, AL

††Department of Medicine, Universidad Peruana Cayetano Heredia, Lima, Perú

‡‡Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.

S.V.P., A.E., M.G., B.A.P.-E., and G.S.A have no conflicts of interest to declare. R.F. has received consulting fees from GSK and Aurinia Pharmaceuticals. F.H. has received consultant fees from GSK, Astra-Zeneca, and Idorsia. B.H.R. has received consulting fees from GSK and Aurinia Pharmacetuicals. G.J.P.-E. is a speaker, is a consultant, and received grants from Pfizer, Janssen, GSK, Sandoz, and Sanofi.

Author contributions: S.V.P., A.E., F.H., M.G., R.F., B.H.R., G.J.P.-E., and G.S.A. contributed to the writing of the original draft. B.A.P.-E., G.P.-E., and G.S.A. contributed to the supervision. G.P.E. and G.S.A. contributed to the review and editing—grammar, style, and language. All authors contributed to the article and approved the submitted version.

This research received no external funding.

Correspondence: Guillermo J. Pons-Estel, PhD, MD, Hospital Clinic de Barcelona, Barcelona, GO-CREAR (Centro Regional Enfermedades Autoinmunes y Reumáticas) CP 2000. Rosario, Argentina, Spain. E-mail: [email protected].